The Future of Analytical and Interpretative Toxicology: Where are We Going and How Do We Get There?

被引:4
|
作者
Wille, Sarah M. R. [1 ]
Elliott, Simon [2 ,3 ]
机构
[1] Natl Inst Criminalist & Criminol, Dept Toxicol, Brussels, Belgium
[2] Elliott Forens Consulting Ltd, Birmingham, W Midlands, England
[3] Kings Coll London, Dept Analyt Environm & Forens Sci, London, England
关键词
DEPENDENT POSTMORTEM REDISTRIBUTION; ALTERNATIVE MATRICES; DRUG-INTERACTIONS; PSYCHOACTIVE SUBSTANCES; ACUTE INTOXICATION; POTENTIAL MARKERS; OPIOID WITHDRAWAL; BAYESIAN NETWORK; BLOOD-SAMPLES; PHARMACOGENETICS;
D O I
10.1093/jat/bkaa133
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
(Forensic) toxicology has faced many challenges, both analytically and interpretatively, especially in relation to an increase in potential drugs of interest. Analytical toxicology and its application to medicine and forensic science have progressed rapidly within the past centuries. Technological innovations have enabled detection of more substances with increasing sensitivity in a variety of matrices. Our understanding of the effects (both intended and unintended) have also increased along with determination and degree of toxicity. However, it is clear there is even more to understand and consider. The analytical focus has been on typical matrices such as blood and urine but other matrices could further increase our understanding, especially in postmortem (PM) situations. Within this context, the role of PM changes and potential redistribution of drugs requires further research and identification of markers of its occurrence and extent. Whilst instrumentation has improved, in the future, nanotechnology may play a role in selective and sensitive analysis as well as bioassays. Toxicologists often only have an advisory impact on pre-analytical and pre-interpretative considerations. The collection of appropriate samples at the right time in an appropriate way as well as obtaining sufficient circumstance background is paramount in ensuring an effective analytical strategy to provide useful results that can be interpreted within context. Nevertheless, key interpretative considerations such as pharmacogenomics and drug-drug interactions as well as determination of tolerance remain and in the future, analytical confirmation of an individual's metabolic profile may support a personalized medicine and judicial approach. This should be supported by the compilation and appropriate application of drug data pursuant to the situation. Specifically, in PM circumstances, data pertaining to where a drug was not/may have been/was contributory will be beneficial with associated pathological considerations. This article describes the challenges faced within toxicology and discusses progress to a future where they are being addressed.
引用
下载
收藏
页码:619 / 632
页数:14
相关论文
共 50 条
  • [21] How do we know where we're going?
    Schwartz, SE
    LUBRICATION ENGINEERING, 1998, 54 (08): : 56 - +
  • [22] FAST the Inside Track: Where We Are, Where Do We Want to Be, and How Do We Get There?
    Danskin, Alan
    Seeman, Dean
    Bouchard, Maxime
    Kammerer, Kerre
    Kilpatrick, Lucy
    Mumbower, Kim
    CATALOGING & CLASSIFICATION QUARTERLY, 2023, 61 (5-6) : 506 - 524
  • [23] Revisiting Rosacea Criteria Where Have We Been, Where Are We Going, and How Will We Get There?
    Saleem, Mohammed D.
    DERMATOLOGIC CLINICS, 2018, 36 (02) : 161 - +
  • [24] Global Dairy Trade: Where Are We, How Did We Get Here and Where Are We Going?
    Vitaliano, Peter
    INTERNATIONAL FOOD AND AGRIBUSINESS MANAGEMENT REVIEW, 2016, 19 (0B): : 27 - 36
  • [25] Before we get there, where are we going?
    Iba, W. (iba@westmont.edu), 2013, Springer Verlag (7407):
  • [26] Japanese political studies: where are we? How did we get here? Where are we going?
    Pempel, T.
    Muramatsu, Michio
    JAPAN FORUM, 2014, 26 (03) : 383 - 405
  • [27] STRUCTURAL FIRE TESTING - WHERE ARE WE, HOW DID WE GET HERE, AND WHERE ARE WE GOING?
    Gales, John
    Maluk, Cristian
    Bisby, Luke
    ICEM15: 15TH INTERNATIONAL CONFERENCE ON EXPERIMENTAL MECHANICS, 2012,
  • [28] The Road to Recovery: Where Are We Going and How Do We Get There? Empirically Driven Conclusions and Future Directions for Service Development and Research
    Laudet, Alexandre B.
    SUBSTANCE USE & MISUSE, 2008, 43 (12-13) : 2001 - 2020
  • [29] Maternal mortality in the United States: Where are we going and how will we get there?
    Hawkins, JL
    Birnbach, DJ
    ANESTHESIA AND ANALGESIA, 2001, 93 (01): : 1 - 3
  • [30] Secondary findings: How did we get here, and where are we going?
    Ormond, Kelly E.
    O'Daniel, Julianne M.
    Kalia, Sarah S.
    JOURNAL OF GENETIC COUNSELING, 2019, 28 (02) : 326 - 333